The protein content of macroalgae varies greatly from phylum to phylum [9]. Generally, the protein fraction of brown seaweeds is low (3–15% of dry weight) compared with that of the green or red seaweeds (10–47% of dry weight) [10]. The protein in macroalgae contains all essential amino acids, however, variations in their concentrations are known to occur [12]. Leucine, valine, and methionine are abundant essential amino acids of Palmaria palmata and their average levels are close to those generally reported for ovalbumin. On the other hand, isoleucine and threonine concentrations are similar to those recorded for legume proteins [6]. Leucine, phenylalanine and valine are the major essential amino acids of Ulva rigida, while levels of histidine, which is an essential amino acid in children, are similar to those found in legumes and eggs [13].

Recently, much attention has been paid to unraveling the structural, compositional and sequential properties of bioactive peptides. Marine bioactive peptides may be produced by one of three methods; solvent extraction, enzymatic hydrolysis or microbial fermentation of marine proteins. However, particularly in food and pharmaceutical industries, the enzymatic hydrolysis method is preferred on account of lack of residual organic solvents or toxic chemicals in the products. Bioactive peptides usually contain 3–20 amino acid residues and their activities are based on their amino acid composition and sequence [14,15]. These peptides are reported to be involved in various biological functions such as antihypertension, immunomodulatory, antithrombotic, antioxidant, anticancer and antimicrobial activities, in addition to nutrient utilisation [15,16].

Among the algal proteins, it is worth noting the occurrence of protein-pigment complexes called phycobiliproteins, some of which are currently used as fluorescent markers in the fields of clinical diagnosis and biotechnological applications [17,18]. Recent studies have shown that phycobiliproteins, which generally make up 1–10% of dry weight of algal biomass, impart antioxidant properties which could be beneficial in the prevention or treatment of several diseases [17]. Moreover, in some countries, phycobiliproteins are utilised as natural food colourings in products such as chewing gums, dairy products, jellies and ice sherbets [4].

Of note, the in vivo digestibility of algal proteins is poorly described, and available studies about their assimilation by humans have not provided conclusive results. Nonetheless, several studies have described a high rate of algal protein degradation in vitro by proteolytic enzymes such as pepsin, pancreatin and pronase. For instance, the in vitro digestibility of proteins from the red seaweed Porphyra tenera is approximately 70%. There is a possibility, however, that the high phenolic content of some algae may limit protein availability in vivo [9].

The lipid content of macroalgae represents only 1–5%, thus its contribution as a food energy source appears to be low [17]. However, PUFAs account for almost half of this lipid fraction, with much of it occurring in the form of omega-3 (n-3) and omega-6 (n-6) fatty acids such as eicosapentanoic acid (EPA) and arachidonic acid (AA) [19]. PUFAs regulate a wide range of functions in the body including blood pressure, blood clotting, and correct development and functioning of the brain and nervous systems [20]. Furthermore, PUFAs have a role in regulating inflammatory responses through the production of inflammatory mediators termed eicosanoids [21].

The n-3 to n-6 ratio of macroalgae is closely matched which may add to their efficacy as a dietary supplement or as part of a balanced diet [22]. Moreover, they contain many essential fatty acids. Red and brown algae, for instance, are particularly rich in the n-3 fatty acids, EPA and α-linolenic acid, and the n-6 fatty acids, AA and linoleic acid, along with relatively high levels of oleic and palmitic acids [11]. In contrast, green seaweeds, like Ulva pertusa, are characterised by the presence of hexadecatetraenoic (n-3), oleic and palmitic acids [23]. The n-3 fatty acid, octadecatetraenoic acid, is abundant in Laminaria sp. and Undaria pinnatifida while hexadecatetraenoic acid is prominent in Ulva sp. [6,24].

In addition to fatty acids, the unsaponifiable fraction of macroalgae contains carotenoids (such as β-carotene, lutein and violaxanthin in red and green seaweeds, fucoxanthin in brown seaweeds), tocopherols, sterols (such as fucosterol in brown seaweeds) and terpenoids [25–28].

Although algal carbohydrate content is relatively high, macroalgae cannot be considered a potential energy rich food as digestibility of these carbohydrates is low [6]. Moreover, the carbohydrate type varies greatly between algae species. Typical polysaccharides in red algae varieties consist of floridean starch, cellulose, xylan and mannan, and the water soluble fibre fraction is formed by sulfur containing galactans such as agar and carrageenan. Standard polysaccharides in brown algae are fucoidan, laminaran, cellulose, alginates and mannitol whilst the fibres are mainly cellulose and insoluble alginates. Most of these polysaccharides are not digestible by the human gastrointestinal tract and, therefore, can be regarded as dietary fibres [11]. The total dietary fibre content of seaweeds ranges from 29.3–62.3 g/100 g [11,19,29], and so is higher than the fibre content of most fruits and vegetables. Human consumption of algal fibre has been proven to be health promoting and its benefits are well documented [13,30,31].

Storage polysaccharides, such as agar, carrageenans and alginates, are the most commercially exploited components in seaweeds. These storage polysaccharides exhibit textural and stabilizing properties [19]; thus they are used in food applications such as thickening aqueous solutions, forming gels, forming water soluble films and stabilizing products such as ice-cream [4].

Fucoidans are a complex series of sulfated polysaccharides found widely in the cell walls of brown macroalgae. Fucoidans are reported to display numerous physiological and biological properties, including anticoagulant, antiviral, antithrombotic, antitumor and antioxidant activities, as well as having an effect on the inflammatory and immune systems [32,33]. In addition, the therapeutic potential of fucoidans increases with their degree of sulfation and they can be easily extracted using either hot water or an acid solution [32]. Another sulfated polysaccharide, porphyran, makes up the main components of the red macroalga, Porphyra [30]. This polysaccharide has reported uses as a gelling agent, a nutritional supplement and as an antioxidant [34]. Alternatively, laminarin, the second major storage glucan in brown algae, has been identified as a modulator of intestinal metabolism through its effects on mucus composition, intestinal pH and short chain fatty acid production [34–36].

Another group of carbohydrate derivatives, oligosaccharides, are commonly defined as carbohydrate molecules with a low degree of polymerisation. Oligosaccharides can be produced naturally or may be derived from algal polysaccharides after chemical, physical or biochemical degradations. To date, numerous oligosaccharides with immunostimulation activities as well as antioxidant and antitumor properties have been characterised. Moreover, oligosaccharides can be beneficial to health when they are added to the diet to enhance the growth of prebiotic bacteria. In this case, oligomers that resist the digestive process are used as a specific substrate for the growth of health beneficial bacteria [37]. For instance, xylo-oligosaccharides and fructo-oligosaccharides are non-digestible oligomers that cannot be absorbed in the gastrointestinal tract. Hence, they are intact in the large bowel and are used as a preferential substrate by anaerobic bacteria such as bifidobacteria and lactobacilli [38,39]. Interestingly, no specific conformation is correlated to the non-digestible oligosaccharide’s biological activity, whereas the immunostimulating, antioxidant, antiangiogenic and antithrombotic activities of poly/oligosaccharides molecules are determined by glycan conformation [37].

While algal polysaccharides have yet to be exploited in the food industry, the fact that they are easy to isolate and have numerous health benefits gives them the potential to serve as valuable bioactive ingredients in functional foods [4].

One of the principal nutritive characteristics of seaweeds is their high antioxidant content (Table 1). In addition, vitamin B₁₂ is found in red macroalgae (e.g., Palmaria longat and Porphyra tenera) and in certain green seaweeds [9]. Red and brown algae contain high levels of folic acid and folate derivatives including 5-metil-tetrahydro-folate, 5-formyl-tetrahydro-folate and tetrahydro-folate. Indeed, amounts as high as 150 μg folic acid per 100 g of dry Undaria pinnatifida algae have been detected [40]. As well as seasonal, environmental and physiological variations, vitamin content also depends on the type of seaweed processing. For example, the content of α-tocopherol in Himanthalia longate dehydrated (33.3 μg/g dry weight) was considerably higher than in canned Himanthalia longate (12 μg/g dry weight) [41].

Seaweeds also contain an incomparable wealth of minerals and trace elements which are attributed to their capacity to retain inorganic marine substances due to the characteristics of their cell surface polysaccharides [6,19,68]. The mineral fraction of some seaweeds accounts for up to 36% of dry matter [17]. Many of these essential minerals accumulate in seaweeds at much higher levels than in terrestrial foodstuffs. For example, there is more iron in an 8 g serving of dry Palmaria palmata than in 100 g of raw sirloin steak [19]. All of the essential minerals and trace elements needed for human nutrition are present in seaweeds [68], and so it should be regarded as a valuable functional food. For instance, the brown algae, Undaria pinnatifida and Sargassum, and the red algae, Chondrus crispus and Gracilariopsis, can be used as food supplements to help meet the recommended daily intake of some minerals (Na, K, Ca, Mg) and trace elements (Fe, Zn, Mn, Cu) [68,69]. Moreover, analysis of the mineral composition of Ulva rigida revealed balanced contents of Na and K (15.9 and 15.6 g/kg respectively, ratio near to 1), which, from a nutritional point of view, is of interest as intake of diets with a high Na/K ratio have been related to incidence of hypertension [13]. Additionally, seaweeds are one of the most important vegetable sources of calcium. Calcium content may be as high as 7% of the dry weight in macroalgae and up to 25–34% in the chalky seaweed, lithotamne. Thus, seaweed consumption may also be useful to those at risk of calcium deficiency, namely expectant mothers, adolescents and the elderly [17].

Other bioactive compounds are the photosynthetic pigments used by autotrophs to capture solar energy for photosynthesis [4]. As regards macroalgae, the main pigments are carotenoids and chlorophylls (Table 1). The carotenoid fucoxanthin has potential commercial value as it has been reported to be of use in treating obesity and reducing the risk of certain diseases, such as type 2 diabetes through its ability to promote the expression of the uncoupling protein, UCP1 [70]. In the food industry, chlorophylls are mainly used as natural colorants in foods and beverages [4]. However, chlorophylls and their derivatives have been shown to possess some biological activity whereby they exhibit anticancer properties in their ability to bind carcinogenic hydrophobic compounds such as polycyclic aromatic hydrocarbons, heterocyclic amines and aflatoxin [71,72]. Phlorotannins, a group of polyphenolic compounds which have also been identified in several brown algal families, have been reported to possess strong antioxidant activity. However, at present, the extractable polyphenol levels from algae are lower than that of other phytochemicals [6,73,74].

The nutritional value ascribed to macroalgae along with their non-animal nature makes them particularly appropriate for use in the food industry. Seaweeds have enormous potential as components of fertilizers, in animal feed supplements, and as additives for human food. Hence, biotechnological advances regarding macroalgae cultivation has stimulated the development of seaweed aquaculture. At present, three genera, Laminaria, Undaria and Porphyra, constitute 93% of the algal mass cultivated for nutritional purposes [6].

The high protein content of various microalgal species and their amino acid pattern, which compares favourably with that of other food proteins, is a good endorsement of microalgae as an alternative protein source [77,78]. Spirulina, for instance, is high in protein (60–70% depending on the strain) and, not only does this protein possess all of the essential amino acids, but these amino acids have excellent bioavailability [52]. Furthermore, the industrial scale growth of the microalga, Dunaliella, can turn out protein extract at about 100 times greater productivity than that reported in agriculture and 50 fold greater than in fish farming [4].

Proteins from marine sources show promise as functional ingredients in foods because they possess numerous important and unique properties such as film and foaming capacity, gel forming ability and antimicrobial activity [4]. In addition, purified peptides from Chlorella vulgaris have demonstrated significant protective effects against cellular damage [79]. With regard to one of the major proteins in Spirulina platensis and Porphyridium, phycobiliprotein, several therapeutic bioactivities have been described, namely, hepatoprotective, anti-inflammatory, immunomodulating, antioxidant and anticancer effects [52].

The average lipid content of algal cells varies between 1 and 70% but can reach 90% of dry weight under certain conditions [80]. Algal lipids are composed of glycerol, sugars or bases esterified to saturated or unsaturated fatty acids. Among all the fatty acids in microalgae, some fatty acids of the n-3 and n-6 families are of particular interest [42]. According to Mendes et al. [60], the main constituents of the lipidic fractions of Chlorella vulgaris are oleic, palmitic and linolenic acids, accounting for 41, 22 and 9% of the total amount, respectively. Additionally, palmitic, linolenic and oleic acids account for more than 85% of the total fatty acid content of Dunaliella salina [81], while the green microalga, Haematococcus, has been shown to contain short chain fatty acids with antimicrobial activity [66].

Higher plants and animals lack the requisite enzymes to synthesize PUFAs of more than 18 carbons and so have to obtain them from their food. Fish and fish oil are the common sources of long chain PUFAs but safety issues have been raised because of the possible accumulation of toxins in fish. Moreover, the application of fish oil as a food additive is limited due to problems associated with its typical fishy smell, unpleasant taste and poor oxidative stability [78]. Consequently, long chain PUFAs are commercially produced via microalgae cultivation for incorporation into infant milk formulations and for use as dietary supplements and food additives [78]. Maximum n-3 fatty acid production can also be induced by altering the growth conditions of microalgae. For instance, under optimal culture conditions, Chlorella minutissima can produce an EPA content of up to 45% of its total fatty acid content [4].

Microalgae such as Porphyridium, which shows a relatively low lipid content, contains significant amounts of several major fatty acids such as palmitic acid, AA, EPA and linoleic acid [46,52]. Spirulina provides an interesting source of γ-linolenic acid (20–25% of the total lipid fraction), which is a precursor of prostaglandins, leukotrienes and thromboxans involved in the modulation of immunological, inflammatory and cardiovascular responses [17]. This microalga is also a natural source of active fatty acids such as lauric, palmitic and oleic acids [82], with the n-3 fatty acid, docosahexaenoic acid (DHA), accounting for up to 9.1% of the total fatty acids content. Spirulina has been found to contain sterols, including clionasterol which has been shown to increase the production of plaminogen-activating factor in vascular endothelial cells [76].

Carbohydrates in microalgae can be found in the form of starch, glucose, sugars and other polysaccharides. Their overall digestibility is high, which is why there is no limitation to using dried whole microalgae in foods or feeds [78]. Moreover, the biological activities of some microalgal species have been associated with polysaccharides. Polysaccharide complexes from Chlorella pyrenoidosa, and possibly Chlorella ellipsoidea, contain glucose and any combination of galactose, rhamnose, mannose, arabinose, N-acetylglucosamide and N-acetylgalactosamine. These complexes are believed to have immunostimulating properties, specifically immune stimulatory activity and can inhibit the proliferation of Listeria monocytogenes and Candida albicans [76]. The most important substance in Chlorella is β-1,3-glucan, which is an active immunostimulator, a free radical scavenger and a reducer of blood lipids. Chlorella can also be used as a food additive owing to the taste and flavour adjusting actions of its colouring agent [78]. Also, novel polysaccharides isolated from Porphyridium and Nostac flegelliforme microalgae exhibited potent antiviral activity against herpes simplex virus (HSV-1 and 2) both in vitro and in vivo [83,84].

The nutritional and therapeutic relevance of dietary carotenoids is attributed to their ability to act as provitamin A; that is, they can be converted into vitamin A by the human body. Moreover, carotenoids play a protective role by preventing the formation of reactive oxygen species [85]. Microalgal production of carotenoids, such as β-carotene and astaxanthin, is an attractive area of research as they are valuable bioactive ingredients that can present at relatively high concentrations in algal cells (Table 1). Moreover, cultivated algae can be induced to produce even larger quantities of carotenoids by controlling certain environmental growth conditions. The strains of microalgae that are currently being investigated for use as natural producers of commercial carotenoids include Dunaliella salina, Sarcina maxima, Chlorella protothecoides, Chlorella vulgaris and Haematococcus pluvialis [4].

Dunaliella salina is the most suitable organism for the mass production of β-carotene as it can produce β-carotene up to 14% of its dry weight [80]. This microalga can also be cultivated easily and quickly when compared to plants and produces both cis and trans isomers of carotenoids for high bioavailability and bioefficacy [85,86]. β-carotene is one of the leading food colorants in the world and has been applied to a range of food and beverage products to improve their appearance to consumers [87]. In addition, β-carotene has strong antioxidant properties which help to mediate the harmful effects of free radicals implicated in numerous life-threatening diseases, including various forms of cancer, coronary heart disease (CHD), premature aging and arthritis. The antioxidant qualities of β-carotene can also assist the body in suppressing the effects of premature aging caused by UV rays [28,86].

Microalgal-derived β-carotene has been reported to be more biologically active than synthetically produced β-carotene and can be marked as a “natural” food additive [4]. Natural β-carotene also contains numerous carotenoids and essential nutrients that are not present in the synthetic form and can be consumed in larger quantities as the body tissues regulate its use [88]. Additionally it has been observed that, under irradiance stress, Dunaliella salina can accumulate significant amounts of xanthophylls, particularly zeaxanthin, which possess unique biological properties with potential for disease prevention [53].

Haematococcus is another unicellular alga that can be used in both open and closed culture systems for the production of antioxidants, namely chlorophylls and carotenoids [4]. Under stress conditions, Haematococcus pluvialis has the ability to accumulate large quantities (1.5–3% of dry weight) of the high value carotenoid, astaxanthin [62]. Besides, the United States Food and Drug Administration for marketing has cleared Haematococcus pluvialis as a dietary supplement and it has also been approved in several European countries for human consumption [76]. With an antioxidant activity up to 10 times stronger than other carotenoids, astaxanthin provides protective activity against cancer, inflammation and UV light. The health benefits of astaxanthin along with its strong colouring properties make it a potential ingredient for use in the nutraceutical, cosmetics, food and feed industries [89].

Microalgae also represent a valuable source of nearly all essential vitamins (A, B₁, B₂, B₆, B₁₂, C, E, nicotinate, biotin, folic acid and pantothenic acid) and are generally rich in chlorophylls (Table 1) [78].

It has clearly been established that microalgae are a rich source of nutritious and biologically active compounds, namely carotenoids, phycobilins, fatty acids, polysaccharides, vitamins and sterols. Nevertheless, not only is it their huge diversity that makes these microorganisms interesting, but also the possibility of growing them at different conditions and using them as natural reactors, leading to an enrichment of some bioactive compounds. However, prior to this, algal material must be analysed for the presence of toxic compounds.

Despite the growing promise of microalgae as a source of food ingredients, the industry has developed with only varying amounts of success and its biotechnological potential remains to be fully exploited [4]. One such future application could be in the production of special lipids. The n-3 fatty acids found in the oils of certain cold water marine fish, which are believed to be capable of reducing the incidence of CHD, are likely to originate from the phytoplankton in food chain. Many of these phytoplankton species are found to be rich in reserves of oils containing various amounts of EPA and DHA [75]. Indeed, the oil obtained from the microalga Schizochytium sp. has been authorized by the United States to be used as a new food ingredient because of its high DHA (n-3) content and because it contains higher levels of squalene and phytosterols but three times less cholesterol than fish oil [6,78].

Fish muscle proteins derived from processing byproducts can be hydrolysed enzymatically to recover protein biomass otherwise discarded as processing waste. Bioactive peptides isolated from various fish protein hydrolysates have shown numerous bioactivities such as antihypertensive, antithrombotic [96–98], anticoagulant [99], immunomodulatory and antioxidative activities [99,100]. Moreover, Jung et al. [101] reported that fish peptides are also capable of accelerating calcium absorption.

Some of the most prevalent marine proteins used in foods are collagen, gelatin and albumin, all of which can be extracted from fish and seafood byproducts [4]. Collagen and gelatin are unique proteins as they are rich in non-polar amino acids (above 80%) such as glycine, alanine, valine and proline [96]. Collagen is a connective tissue protein found in skin, bones, cartilage, and ligaments which can be extracted from fish processing byproducts [4]. Collagen derived from species living in warmer environments (e.g., tuna) have higher contents of proline and hydroxyproline, so they present a higher melting point and superior thermal stability than those from fish that live in cooler environments (e.g., cod) [93]. Gelatin is a protein product formed by the partial hydrolysis of collagen. It has a unique gel forming ability [4] and is used as a food additive to increase the texture, the water holding capacity and stability of several food products [92]. Traditionally, gelatin has been derived from beef or pork; however, marine gelatin can also be extracted from the skins of flatfish, cold water fish species or alternative sources such as squid and octopus [4,102]. Gelatin possesses a characteristic melt-in-the-mouth property, which makes it suitable to a wide range of applications in food and pharmaceutical industries; in particular, fish gelatin has a better release of aroma and shows a higher digestibility than animal gelatin [103].

Other bioactive proteins that can be obtained from marine processing include albumin and protamine. Albumin, has exhibited several properties that make it beneficial to human health, such as antioxidant and anticoagulatory activities and the ability to maintain microvascular integrity [104]. While it is typically derived from egg whites, albumin can also be isolated from mollusks, crustaceans and low fat fish [4]. Protamine is a simple peptide consisting largely of arginine residues that is found in the testicles of more than 50 fish species. Protamine is a promising antibacterial agent in food processing and preservation as it has the ability to prevent growth of Bacillus spores [92]. Also, major marine enzymes are produced as a result of fish and shellfish processing. These enzymes are valuable as food ingredients and in food processing due to their specificity, diverse properties, salt tolerance, and high activity at mild pH [4]. However, different opinions exist as to the cost and economy in extracting these enzymes as opposed to having them produced by microorganisms.

Better utilization of marine fish processing byproducts could be achieved by converting these materials into fish oil [96]. The liver of lean white fish such as cod species, the muscle of fatty fish (herring, mackerel, salmon) and offal generated from processing are all good sources of marine lipids [92,96]. The fat content of fish varies from 2–30% and is mainly composed of two types of PUFAs, EPA and DHA [96]. Compared to saturated fats, PUFAs in fish oil are readily digested for energy production [96] and are believed to be the main protective components of fish oil that act against certain types of diseases.

Cod liver oil has long been used as a fish oil supplement as it contains high amounts of PUFAs, much of which is the n-3 fatty acid, EPA [105]. Although supplements are popular in Europe and Japan, a more attractive option for many in the food industry is to enrich everyday products like bread, egg, margarine etc. with n-3 long chain PUFAs [4]. However, the main factor limiting the application of these PUFAs in food products is their susceptibility to lipid oxidation, which can result in strong fishy odours and flavours [4,92].

Chitin is ubiquitous in marine polysaccharides; it is one of the major structural components of crustacean shells and shellfish wastes with a structure similar to that of cellulose, and built from n-acetyl-glucosamine monomers [106]. On a dry weight basis, shrimp, crab, lobster, prawn and crayfish have been reported to contain between 14 and 35% chitin, while deproteinized dry shell waste of Antarctic krill contains approximately 40% crude chitin. As the insolubility of chitin hampers most of its applications, once isolated, chitin can be deacetylated to create chitosan, a large cationic polymer with numerous commercial applications in the food, pharmaceutical and waste treatment industries [4]. In practice, chitin is used almost exclusively as raw material for production of chitosan, oligosaccharides and glucosamine [93]. There are a variety of food applications for chitin, chitosan and their derivatives, including use as antimicrobial agents, edible films, additives, nutraceuticals (e.g., increasing dietary fibre, reducing lipid absorption) and water purifiers [107].

Chito-oligosaccharides are chitosan derivatives that can be generated via chemical or enzymatic hydrolysis of chitosan. Recently, these oligosaccharides have been the subject of increased attention in terms of their pharmaceutical and medicinal applications, due to lack of toxicity, high solubility and their positive physiological effects such as angiotensin-I-converting enzyme (ACE) inhibition, antioxidant, antimicrobial, anticancer, immunostimulant, hypocholesterolemic, hypoglycemic and anticoagulant properties [31].

Fish bone, which is separated after removal of muscle proteins on the frame, is a valuable source of calcium, which is an essential element for human health. As calcium is deficient in most regular diets, demand for calcium fortified products is growing continuously, and fish bone material is a useful source [108]. However, in order to incorporate fish bone into calcium fortified food it needs to be converted into an edible form by softening its structure [96].

Astaxanthin represents between 74 and 98% of the total pigments in shellfish. Due to these high contents, crustacean shells can not only be used for recovery of chitin but also for recovery of astaxanthin. Owing to its useful properties, astaxanthin from natural sources is increasingly being marketed as a functional food ingredient with prices ranging between $3,000 and $12,000 per kg. The methods currently available for the extraction of astaxanthin from shell matrices employ different elements such as edible oils, hydrochloric acid and organic solvents. Also, a feasible technique for partial concentration of astaxanthin from crustacean shells is via lactic acid fermentation, which also has the advantage of protecting the biomass from bacterial decomposition. The silage formed contains insoluble chitin, a protein rich fraction, and a lipid rich fraction composed of astaxanthin, sterols, and vitamins A and E [93].

The majority of bioactive marine molecules have been isolated from benthic species such as sponges, bryozoans, echinoderms, polychaetes, ascidians, mollusks and cnidarians [109]. These molecules have recognized applications against cancer, inflammation, HIV-AIDS, thrombotic disorders and infectious diseases [110]. In fact, more ascidian- and sponge-derived compounds are in clinical and preclinical trials than compounds from any other marine taxa [109].

An emerging source of new bioactive ingredients may result from the microbial diversity in the marine environment, particularly those microbes associated with marine plants and animals. Several studies have demonstrated that “living surfaces” represent an environment rich in epibiotic microorganisms that produce bioactives [111]. Many of these marine microorganisms can be easily cultured and manipulated in bioreactors and, therefore, represent an excellent renewable source of biologically active compounds. Some deep sea bacteria have been found to contain large amounts of EPA and DHA, presumably to allow their membranes to be fluid and adaptive to extreme temperatures and pressures [4]. For example, Mortierella alpina can produce EPA as 15% of total extractable fatty acid at 12 °C [112]. Moreover, extremophiles contain polysaccharides with a wide variety of chemical and physical properties that are often not present in or are variations of the more traditional, terrestrial plant-derived polysaccharides. One strain of Alteromonas has been found to produce an anionic exopolysaccharide with potential use as a thickening agent, while other Altermonas strains produced polymers with qualities such as unusual gelling properties, significant thickening ability, and high metal binding capacity [113]. In addition, halophiles such as Halobacterium mediterranei have been reported to contain exopolysaccharides with highly favourable rheological properties and resistance to high salinities, temperatures and pH [4]. Other promising sources of functional food ingredients include a red coloured bacterium obtained from Puerto Rico which was found to excrete vitamin B and antibacterial substances into the sea water [75], while Dharmaraj et al. [114] confirmed the production of food grade carotenoids by Streptomyces microbes isolated from the marine sponge Callyspongia diffusa.

Lower invertebrates, such as sponges, represent a great diversity of lipid components, such as fatty acids, sterols, and other unsaponifiable compounds, as well as compounds such as bioactive terpenes, cyclic peptides, alkaloids, peroxides, and amino acid derivatives [115]. However, sponge mariculture has not yet proven to be very lucrative as little is known about how to replicate the sponge’s natural environment and life cycle. Also, the bioactive compounds of interest are often only produced in trace amounts [4,115].

Another prospective source of n-3 long chain PUFAs is the class of algae-like fungi called phycomycetes. These marine fungi have been reported to produce significant levels of γ-linolenic acid, AA, EPA and DHA [4].

Wijesekara et al. [129] recently reported that algal sulfated polysaccharides have potent capacities for new anticancer product developments in the pharmaceutical as well as the food industries. Indeed, several in vivo mouse studies have demonstrated the antitumor activity of marine-based polysaccharides [94,160–164]. Moreover, non-digestible oligosaccharides, which are found in abundance in macroalgae, are known to improve gut microecology and in doing so may reduce the risk of colon cancer. In a review by Mussatto and Mancilha [38], the authors state that intake of transgalactosylated disaccharides reduces the faecal pH as well as ammonia, p-cresol and indole concentrations, with an increase in bifidobacteria and lactobacilli and a decrease in Bacteroidaceae populations. As these changes in faecal physiological parameters are believed to reduce the risk of cancer development, macroalgal non-digestible oligosaccharides could be considered as potential anticarcinogenic food ingredients [34,38].

While the cardioprotective effects of fish oil n-3 PUFAs are well established, their antitumoral effects are not widely acknowledged. However, promising data from experimental studies carried out in animals show that elevated supplies of EPA, DHA and/or fish oil diet supplementation generally inhibit tumor growth and metastases occurrence [121,122,165–167]. Using a mouse model of MDA-MB-231 human breast cancer cell metastasis to bone, research by Mandal et al. [120] found that a fish oil diet enriched in DHA and EPA prevented the formation of osteolytic lesions in bone, indicating suppression of cancer cell metastasis to bone. The study also revealed markedly reduced levels of CD44 mRNA and protein (associated with generation of cancer stem cells) in the tumors of mice fed fish oil diet compared to those fed the control diet. Furthermore, Brown and colleagues [168] provided in vitro evidence supporting epidemiological data that the dietary ratio of n-3:n-6 is crucial in determining the risk of metastatic disease in prostate cancer. Increasing the ratio of n-3 to n-6 PUFAs, in particular increasing the amount of EPA in the diet, can inhibit the metastatic process by blocking the production of prostaglandin E2 and thereby reducing the risk of aggressive disease.

Being lipid soluble, carotenoids are absorbed with fats and circulate bound to different lipoproteins. The principal biological effects of carotenoids relate to their antioxidant properties, which form the basis of potential protection against lipid peroxidation, atherogenesis, DNA oxidation, and cancer [169]. Carotenoids have been implicated in the inhibition of cancer cells in vitro [170–172], in animal models [173,174] and in humans, as important dietary phytonutrients having cancer preventive activity for lung, colon, breast and prostate cancer [175,176]. As regards marine-sourced carotenoids, Cha et al. [134] found that the carotenoid extract of Chlorella ellipsoidea exerted strong antiproliferative effects on human colon cancer cells, including induction of apoptosis. The authors suggest that bioactive xanthophylls of C. ellipsoidea could be potential therapeutic agents in the prevention of human cancers. Several studies have also demonstrated the anticancer activity of astaxanthin in mammals [177–179].

The cancer preventative effect of chlorophyll derivatives have been extensively studied, with particular emphasis on their in vitro antimutagenic activity against numerous dietary and environmental mutagens [180–184]. In a study presented by Chernomorsky et al. [71], the authors conclude that food sources that yield chlorophyll derivatives may play a significant role in cancer prevention. They found that dietary chlorophyll derivatives exhibit antimutagenic effects and reduce tumor cell growth. Indeed, epidemiological evidence has linked diets high in chlorophyll with a reduced risk of colon cancer in humans [185]. Antioxidant activity, mutagen trapping, modulation of detoxification pathways, and induction of apoptosis in cancer cells have been highlighted as possible modes of actions responsible for chlorophyll’s protective effects in vivo [186].

Neither carotenoids nor chlorophylls can be synthesized by animal tissues [187]. Thus, these molecules must be obtained from food and, as previously illustrated, the marine environment represents an endless resource. Carotenoid and chlorophyll molecules can be extracted and used as natural colorants and antioxidants to restore the natural level of these molecules in food or to prepare fortified products. They can also be chemically modified before being incorporated into food products [187]. Overall, positive data from in vitro and animal studies have prompted an increased interest in the potential usefulness of carotenoids and chlorophylls as preventative agents for human populations at elevated risk of development of specific cancers [186].

Numerous epidemiological studies have shown a strong correlation between high fibre diets and a lower incidence of chronic disorders such as CVD [189–193]. Soluble fibre forms a viscous indigestible mass in the gut and helps trap digestive enzymes, cholesterol, starch, glucose, and toxins which are then expelled through the faeces. The soluble fraction of fibres has a hypocholesterolemic effect, possibly due to augmented gastrointestinal content interfering with micelle formation and lipid absorption, or an increase and excretion of neutral sterols and biliary acids. Given that seaweed contain a large amount of soluble polysaccharides, they therefore have potential function as dietary fibre [194]. Additionally, several investigators have reported that water soluble fractions of seaweeds or isolated algal polysaccharides induce hypocholesterolemic and antihypertensive effects in experimental animals [131,195,196]. Indeed, sodium alginate and fucoidan were found to decrease serum cholesterol levels in vivo [132,133,197].

The amount of fat in the diet and the type of fatty acids consumed can influence the likelihood of CVD and its risk factors [22]. The first recognition of the beneficial effect of fatty acids on CVD came from the observations on the longevity of Eskimos, which was later attributed to the high contents of fish-derived n-3 long chain fatty acids (e.g., EPA and DHA) in their diets [198–201]. Since then, the cardioprotective effects of fish oil n-3 PUFAs appear well determined. Numerous epidemiological and experimental studies have conclusively shown that diets rich in fish and fish oils are associated with a reduced risk of CVD [202–211]. The omega-3 index, a proposed biomarker for CVD risk, is the level of EPA and DHA in red blood cell membranes (expressed as a percent of total fatty acids), and an index of 8% or greater has been posed as a target for reducing CVD [212]. Research carried out by Lerman et al. [213] found that provision of 2–3 g/day of EPA and DHA for 12 weeks increased the omega-3 index by 3.7 to 4.1 percentage points to cardioprotective levels. Moreover, fish oil supplementation has been shown to be beneficial in controlling high blood pressure [214–216].

High blood pressure (hypertension) is one of the major independent risk factors for CVD [217]. ACE plays a crucial role in the regulation of blood pressure [15], and so ACE inhibition is considered to be a useful therapeutic approach in the treatment of hypertension. Numerous investigations of marine-derived peptides have revealed potent antihypertensive and ACE inhibitory activities in hypertensive rats [218–221]. According to Lee et al. [222], a single oral administration of a peptide derived from tuna frame protein hydrolysate showed a strong suppressive effect on systolic blood pressure of spontaneously hypertensive rats and this antihypertensive activity was similar to that of captopril, a commercial antihypertensive drug. Therefore, due to their effectiveness in both prevention and treatment of hypertension, marine-derived bioactive peptides have prospective use as functional ingredients [15].

Due to their antioxidant properties, carotenoids are believed to have therapeutic benefit in treating CVD [223,224]. In addition, astaxanthin, a carotenoid ubiquitous in the marine environment, exhibits anti-atherogenic effects. In a study involving hyperlipidemic rabbits, astaxanthin significantly reduced macrophage infiltration in lesions and lowered the occurrence of macrophage apoptosis and plaque ruptures [225]. Indeed, results of human intervention trials indicate that consumption of natural astaxanthin could contribute to prevention of atherosclerosis. Iwamoto et al. [226] reported a dose response relationship between astaxanthin and LDL oxidation time, while Yoshida and colleagues [227] recently demonstrated that astaxanthin intake ameliorates triglyceride and HDL cholesterol in correlation with increased adiponectin. Antihypertensive effects were also revealed when oral administration of astaxanthin for 14 days induced a significant reduction in arterial blood pressure in spontaneously hypertensive rats [228]. Furthermore, in a follow-up study, the authors suggest that astaxanthin could modulate the oxidative condition and may improve vascular elastin and arterial wall thickness in hypertension [229].

As diet is now recognised as an important modifiable risk factor for CVD, the incorporation of marine bioactives in food could benefit heart health by modifying blood levels of HDL and LDL cholesterol, as well as reducing hypertension (Figure 1). In particular, n-3 PUFAs and astaxanthin have use as dietary supplements for the prevention or the alleviation of certain CVD as they also reduce inflammation often associated with the development of CHD. Besides, several comprehensive reviews examine the literature on pharmacological studies of marine natural compounds that affect the cardiovascular system [145,230,231].

Arthritis describes a condition involving inflammation of the joints and is a disease affecting mostly the aged population. Preventing inflammation with its associated pain and reduced mobility symptoms is a primary requirement in arthritis treatment [194]. Due to the involvement of inflammatory eicosanoids in the aetiology of this disorder, diet may be a potential therapeutic agent [22], and so the importance of dietary PUFAs in the treatment of arthritis has been greatly investigated [239–241]. Meta-analysis of 17 randomised, controlled trials was conducted by Goldberg and Katz [233] to assess the analgesic effects of n-3 PUFAs in patients with rheumatoid arthritis or joint pain. Favourable outcomes such as reduced patient reported joint pain intensity, minutes of morning stiffness, number of painful and/or tender joints and reduced non-steroidal anti-inflammatory drugs consumption were reported following 3 to 4 months supplementation with n-3 PUFAs. In fact, the authors conclude that n-3 PUFA supplementation is an attractive adjunctive treatment for joint pain.

In addition to n-3 PUFAs, clinical investigations suggest that ingestion of collagen hydrolysates, which can be isolated from fish waste, reduces pain in patients suffering from osteoarthritis [242].

Fish oil or fish containing more than 2% fat has been found to have a reduced risk of airway hyperresponsiveness, and children who regularly eat fresh, oily fresh have a reduced risk of developing asthma than children who rarely eat fish [243,244]. Supplementation of diet with n-3 fatty acids also confirmed their benefit in the reduction of breathing difficulties and other symptoms, along with reduced drug doses required by asthma patients. During treatment, the increase in the content of n-3 fatty acids in cell membranes was reported to take place at the expense of AA resulting in the competitive inhibition of pro-inflammatory eicosanoid production and production of anti-inflammatory eicosanoids [194,245,246]. Moreover, a number of interventional studies have demonstrated improvement in asthmatic status following n-3 PUFA supplementation [247–249]. Emelyanov et al. [123] assessed the effect of n-3 PUFA rich lipid extract of New Zealand green lipped mussel on symptoms, peak expiratory flow and exhaled hydrogen peroxide (a marker of airway inflammation) in patients with atopic asthma. This double blind randomised trial revealed a significant decrease in daytime wheeze, reduction in the concentration of exhaled hydrogen peroxide and an increase in morning peak expiratory flow compared to the placebo group.

Recently, there has been recognition of an inflammatory component to the pathology of neurodegeneration, most notably in Alzheimer’s disease but also in Parkinson’s disease and motor neuron disease [250]. As anti-inflammatory n-3 PUFAs are preferentially incorporated in the brain, a diet rich in EPA and DHA could keep neuroinflammation at a minimum [251]. In fact, elderly people who eat fish or seafood, that are highly enriched in n-3 PUFAs, at least once a week, have been shown to be at lower risk of developing dementia including Alzheimer’s disease [252,253].

Evidence is also emerging which suggests that marine algae could possess therapeutic activities for combating neurodegenerative diseases associated with neuroinflammation. Jin and colleagues [254] found that Ulva conglobata extract almost completely suppressed the expression of the pro-inflammatory enzyme cyclooxygenase-2 (COX-2) and inducible nitric oxide (iNOS) in murine BV2 microglia. Similarly, the brown alga, Ecklonia cava, was reported to induce significant inhibition of NF-κB dependent cytokines as well as iNOS and COX-2, thus reducing inflammation [255]. In addition, red alga Neorhodomela aculeate could be considered as a potential neuroprotective and anti-inflammatory agent to treat aging related neurological disorders [256]. However, as highlighted by the authors, further studies are needed to determine which components of each of the algae contribute to the observed anti-inflammatory activities.

As well as the nutritional bioactives discussed, numerous anti-inflammatory compounds with potential pharmacological applications have been isolated from marine sources [7,145,230,231,257,258]. Nevertheless, n-3 PUFAs appear to be the most prominent and most promising anti-inflammatory agents. In spite of this, there have not been sufficient studies to warrant a dietary recommendation regarding the use of n-3 PUFAs in the management of inflammatory conditions, and so there is a need for more carefully designed and controlled clinical trials in the therapeutic applications of n-3 fatty acids [22]. There is, however, a potential complementary role between drug therapy and a diet rich in n-3 PUFAs. An increased intake of n-3 fatty acids may increase the efficacy of anti-inflammatory medications, and perhaps reduce the need for conventional drugs. This dietary choice could be achieved through the use of marine-sourced PUFAs as fortificants in margarine, dairy products (milk, yoghurt, cheese), breads and baked goods, meat-based and fish-based meals, for example.